Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2017-11-23 2017-11-23
Drug Identification Number 02241919 02241919
Brand name MARCAINE 5 MG/ML MARCAINE 5 MG/ML
Common or Proper name MARCAINE MARCAINE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE
Strength(s) 5.0MG 5.0MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION EPIDURAL
Packaging size 10x10ml 10x10ml
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-02-05 2018-02-05
Actual start date
Estimated end date Unknown Unknown
Actual end date 2017-09-30 2017-09-30
Shortage status Avoided shortage Avoided shortage
Company comments Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions. Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.
Health Canada comments